Evidence map›Paper›PMID 35308885›Full record

ArticleFrontiers in psychiatry2022

Efficacy and Safety of Q10 Ubiquinol With Vitamins B and E in Neurodevelopmental Disorders: A Retrospective Chart Review.

Francesca Cucinotta, Arianna Ricciardello, Laura Turriziani, Arianna Mancini, Roberto Keller, Roberto Sacco, Antonio M Persico

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06623227 (Randomized, Placebo-controlled, Double-blind Study of Increasing Total Antioxidant Capacity with Vitamin E and C in Two Cohorts of Patients with Autism Spectrum Disorders), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06623227 naenrolling by invitationnot on this mapstarted 2024, after this paper: background citation

Randomized, Placebo-controlled, Double-blind Study of Increasing Total Antioxidant Capacity with Vitamin E and C in Two Cohorts of Patients with Autism Spectrum Disorders

TypeinterventionalSponsorRinvil RenaldiRan2024 to 2025Enrolled50ConditionsAutism Spectrum DisorderArmsPlacebo, Vitamin E and C
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Francesca CucinottaInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital, Messina, Italy.
Arianna RicciardelloInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital, Messina, Italy.
Laura TurrizianiInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital, Messina, Italy.
Arianna ManciniInterdepartmental Program "Autism 0-90", "G. Martino" University Hospital, Messina, Italy.
Roberto KellerMental Health Department, Adult Autism Centre, Rete Ospedaliera Territorio Nord-Ovest, Azienda Sanitaria Locale Città di Torino, Turin, Italy.
Roberto SaccoService for Neurodevelopmental Disorders, University "Campus Bio-Medico", Rome, Italy.
Antonio M PersicoChild and Adolescent Neuropsychiatry Program, Modena University Hospital and Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Azienda Ospedaliera Universitaria Policlinico "G. Martino" · ITASL Roma · ITUniversità Campus Bio-Medico · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased oxidative stress and defective mitochondrial functioning are shared features among many brain disorders. The aim of this study was to verify retrospectively the clinical efficacy and safety of a metabolic support therapy with Q10 ubiquinol, vitamin E and complex-B vitamins in various neurodevelopmental disorders. This retrospective chart review study included 59 patients (mean age 10.1 ± 1.2 y.o., range 2.5-39 years; M:F = 2.47:1), diagnosed with Autism Spectrum Disorder (

Indexed as

Autism Spectrum Disordercoenzyme Q10Intellectual Disabilityneurodevelopmental disordersPhelan-McDermid syndromeUbiquinol-10vitamin Bvitamin E

Identifiers

PMID35308885
PMCPMC8927903
OpenAlexW4214865016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.